VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 239,681,066
- Share change
- +1,952,951
- Total reported value
- $35,912,095,840
- Put/Call ratio
- 85%
- Price per share
- $149.86
- Number of holders
- 637
- Value change
- +$288,569,706
- Number of buys
- 312
- Number of sells
- 262
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
10%
|
26,478,714
|
$4,025,823,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.7%
|
19,735,921
|
$3,000,648,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
17,612,047
|
$2,677,736,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
6.5%
|
16,560,445
|
$2,517,851,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.2%
|
13,267,346
|
$2,017,168,000 | — | 30 Sep 2017 | |
| Capital World Investors |
13F
|
Company |
4.5%
|
11,561,841
|
$1,757,862,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
11,218,527
|
$1,705,669,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.7%
|
9,322,447
|
$1,394,827,000 | — | 30 Sep 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.8%
|
7,080,171
|
$1,076,469,000 | — | 30 Sep 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.4%
|
6,017,766
|
$914,941,000 | — | 30 Sep 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.1%
|
5,432,080
|
$825,872,000 | — | 30 Sep 2017 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.4%
|
3,600,241
|
$547,381,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
3,095,015
|
$470,564,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,893,380
|
$439,910,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,696,704
|
$410,006,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
2,501,568
|
$379,582,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.85%
|
2,158,588
|
$328,192,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0.84%
|
2,149,324
|
$326,783,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.81%
|
2,074,302
|
$315,377,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.78%
|
1,994,410
|
$303,230,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.78%
|
1,977,269
|
$300,624,000 | — | 30 Sep 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
1,890,690
|
$287,461,000 | — | 30 Sep 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
1,725,683
|
$262,373,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.65%
|
1,668,208
|
$253,634,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.6%
|
1,516,180
|
$230,520,000 | — | 30 Sep 2017 | |
| BB BIOTECH AG |
13F
|
Company |
0.58%
|
1,475,445
|
$224,327,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.54%
|
1,368,020
|
$207,994,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
1,347,609
|
$204,891,000 | — | 30 Sep 2017 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.5%
|
1,271,676
|
$193,345,000 | — | 30 Sep 2017 | |
| Jupiter Investment Management Ltd |
13F
|
Company |
0.47%
|
1,202,030
|
$182,756,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.46%
|
1,177,268
|
$178,992,000 | — | 30 Sep 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.46%
|
1,159,914
|
$176,353,000 | — | 30 Sep 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.44%
|
1,117,737
|
$169,940,733 | — | 30 Sep 2017 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.42%
|
1,079,441
|
$164,119,000 | — | 30 Sep 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.41%
|
1,036,181
|
$157,541,000 | — | 30 Sep 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.4%
|
1,028,004
|
$156,298,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
991,786
|
$150,787,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
925,075
|
$140,649,000 | — | 30 Sep 2017 | |
| Swiss National Bank |
13F
|
Company |
0.36%
|
918,209
|
$139,604,000 | — | 30 Sep 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.36%
|
909,230
|
$138,239,000 | — | 30 Sep 2017 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.35%
|
893,380
|
$135,829,000 | — | 30 Sep 2017 | |
| MANNING & NAPIER ADVISORS LLC |
13F
|
Company |
0.35%
|
885,868
|
$134,686,000 | — | 30 Sep 2017 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.36%
|
910,702
|
$132,624,000 | — | 30 Sep 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
859,250
|
$130,640,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
834,257
|
$126,841,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.32%
|
822,531
|
$125,058,000 | — | 30 Sep 2017 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.31%
|
785,050
|
$119,359,000 | — | 30 Sep 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
758,328
|
$115,296,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.3%
|
756,860
|
$115,073,000 | — | 30 Sep 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.29%
|
731,123
|
$111,160,000 | — | 30 Sep 2017 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2017
As of 31 Dec 2017,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
637 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
239,681,066 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Vanguard Group Inc, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, JPMORGAN CHASE & CO, Clearbridge Investments, LLC, Capital World Investors, and JENNISON ASSOCIATES LLC.
This page lists
638
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
605
Q4 2017 holders
637
Holder diff
32
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.